fda 503a bulks list bpc-157 panel backs compounded BPC-157, KPV peptides in win for RFK Jr The FDA just dropped a

Instead, approved interventions are stratified according to a patient's body mass index (BMI), the presence of weight-related health conditions, and their individual clinical circumstances

Ehsan Sadri, an ophthalmologist and researcher based in Newport Beach, CA, was issued a warning letter from FDA for failing to adhere to clinical trial protocols

GLP-1 receptor agonists may reduce symptoms through anti-inflammatory and metabolic mechanisms, but they do not eliminate endometrial implants or cure the underlying condition

As of 2025, nearly 100 peptide-based drugs have received regulatory approval worldwide, with more than 200 in active clinical development